About Us
Corporate Officers
Board of Directors
Community Citizenship
Our Brands
Makena
®
(hydroxyprogesterone caproate injection)
Evamist
®
(estradiol transdermal spray)
Clindesse
®
(clindamycin phosphate)
Gynazole-1
®
(Butoconazole Nitrate Vaginal Cream USP, 2%)
Ask the Healthcare Professional
Investor Relations
SEC Filings
News »
Recent Headlines
Press Releases
Conference Calls
Media Contacts
Upcoming Investor Events
Investor FAQs
Investor Contacts
Corporate Governance
Corporate Officers
Board of Directors
Research & Development
Update on Ongoing Makena
®
(hydroxyprogesterone caproate
injection) Research
5/24/2013 9:31:00 AM
KVPHQ:
KVPBQ:
Conference Calls
Company will update accordingly as conference calls are scheduled.
Home
|
Contact Us
|
Site Directory
|
Legal/Privacy
|
Compliance Program
©2013 KV Pharmaceutical Company. All Rights Reserved.